Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/08/13 → 31/08/14 |
A Phase 2 randomised double blind study comparing tremelimumab to placebo in second or third treatment of subjects with unresectable pleural or peritonela malignant mesothelioma
- Parente, Phillip (Primary Chief Investigator (PCI))
Project: Research